Rabbit Recombinant Monoclonal CABP antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
IP | Flow Cyt | WB | IHC-P | ICC/IF | |
---|---|---|---|---|---|
Human | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Predicted | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse | Dilution info - | Notes - |
Modulates calcium-dependent activity of inositol 1,4,5-triphosphate receptors (ITPRs) (PubMed:14570872). Inhibits agonist-induced intracellular calcium signaling (PubMed:15980432). Enhances inactivation and does not support calcium-dependent facilitation of voltage-dependent P/Q-type calcium channels (PubMed:11865310). Causes calcium-dependent facilitation and inhibits inactivation of L-type calcium channels by binding to the same sites as calmodulin in the C-terminal domain of CACNA1C, but has an opposite effect on channel function (PubMed:15140941). Suppresses the calcium-dependent inactivation of CACNA1D (By similarity). Inhibits TRPC5 channels (PubMed:15895247). Prevents NMDA receptor-induced cellular degeneration. Required for the normal transfer of light signals through the retina (By similarity).
Calcium-binding protein 1, CaBP1, Calbrain, Caldendrin, CABP1
Rabbit Recombinant Monoclonal CABP antibody. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
CABP or Calcium-Binding Protein is a protein that modulates calcium signaling pathways. Alternate names include calbindin and calretinin though these may refer to specific types within the broader CABP family. CABP proteins vary in mass generally ranging from 10 to 50 kDa depending on the specific family member. These proteins are mainly expressed in the nervous system where they play an important role in regulating intracellular calcium levels. They also appear in other tissues like the heart and kidneys where they contribute to various cellular functions.
The regulation of calcium ions by CABP influences several processes including neurotransmitter release muscle contraction and cell division. CABP proteins can be parts of larger complexes where they interact with other calcium-binding proteins to modulate calcium-dependent signaling mechanisms. Their function in the regulation of calcium homeostasis suggests a direct involvement in maintaining normal cellular functions especially in neurons.
CABP proteins play integral roles in calcium signaling and related pathways. They are critical in modulating the response of cells to calcium transients by interacting with proteins such as calmodulin and calcineurin. CABP's role in these calcium-mediated pathways ensures proper synaptic activity and muscle response and is important for the plasticity of neuronal connections critical for learning and memory.
The dysfunction of CABP has links to neurodegenerative disorders and cardiac diseases. Alterations in CABP expression can contribute to conditions like Alzheimer's disease where calcium signaling becomes dysregulated. In addition aberrant CABP function may also play a role in cardiac hypertrophy due to imbalanced calcium handling often involving calmodulin and other calcium-dependent molecules. Understanding CABP's involvement in these conditions could provide insights into potential therapeutic strategies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-CABP antibody [EPR7916] (ab128910) at 1/1000 dilution
Lane 1: Y79 cell lysate at 10 µg
Lane 2: U-87 MG cell lysate at 10 µg
All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 40 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com